Assessment of cough in head and neck cancer patients at risk for dysphagia-An overview.


Journal

Cancer reports (Hoboken, N.J.)
ISSN: 2573-8348
Titre abrégé: Cancer Rep (Hoboken)
Pays: United States
ID NLM: 101747728

Informations de publication

Date de publication:
10 2021
Historique:
revised: 22 02 2021
received: 09 12 2020
accepted: 26 03 2021
pubmed: 2 5 2021
medline: 8 3 2022
entrez: 1 5 2021
Statut: ppublish

Résumé

This literature review explores the terminology, the neurophysiology, and the assessment of cough in general, in the framework of dysphagia and regarding head and neck cancer patients at risk for dysphagia. In the dysphagic population, cough is currently assessed perceptually during a clinical swallowing evaluation or aerodynamically. Recent findings have shown intra and inter-rater disagreements regarding perceptual scoring of cough. Also, aerodynamic measurements are impractical in a routine bedside assessment. Coughing, however, is considered to be a clinically relevant sign of aspiration and dysphagia in head and cancer patients treated with concurrent chemoradiotherapy. This article surveys the literature regarding the established cough assessment and stresses the need to implement innovative methods for assessing cough in head and neck cancer patients treated with concurrent chemoradiotherapy at risk for dysphagia.

Sections du résumé

BACKGROUND
This literature review explores the terminology, the neurophysiology, and the assessment of cough in general, in the framework of dysphagia and regarding head and neck cancer patients at risk for dysphagia. In the dysphagic population, cough is currently assessed perceptually during a clinical swallowing evaluation or aerodynamically.
RECENT FINDINGS
Recent findings have shown intra and inter-rater disagreements regarding perceptual scoring of cough. Also, aerodynamic measurements are impractical in a routine bedside assessment. Coughing, however, is considered to be a clinically relevant sign of aspiration and dysphagia in head and cancer patients treated with concurrent chemoradiotherapy.
CONCLUSION
This article surveys the literature regarding the established cough assessment and stresses the need to implement innovative methods for assessing cough in head and neck cancer patients treated with concurrent chemoradiotherapy at risk for dysphagia.

Identifiants

pubmed: 33932152
doi: 10.1002/cnr2.1395
pmc: PMC8551981
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1395

Informations de copyright

© 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.

Références

Chest. 2006 Aug;130(2):379-85
pubmed: 16899835
Int J Speech Lang Pathol. 2013 Apr;15(2):209-15
pubmed: 22873621
Acta Oncol. 2013 Feb;52(2):270-6
pubmed: 23173758
Radiother Oncol. 2015 Oct;117(1):139-44
pubmed: 26320608
Cancer Rep (Hoboken). 2021 Oct;4(5):e1395
pubmed: 33932152
Radiother Oncol. 2006 Sep;80(3):302-6
pubmed: 16890314
Arch Phys Med Rehabil. 2015 Oct;96(10):1866-72
pubmed: 26184890
Respir Med. 2017 Nov;132:95-101
pubmed: 29229113
J Neurosci. 2011 Feb 23;31(8):2948-58
pubmed: 21414916
Lung. 2017 Jun;195(3):289-294
pubmed: 28353117
Dysphagia. 2016 Jun;31(3):339-51
pubmed: 27098922
Proc Biol Sci. 2020 Jun 10;287(1928):20200944
pubmed: 32517611
Ann Rehabil Med. 2014 Aug;38(4):476-84
pubmed: 25229026
Head Neck. 2016 Apr;38 Suppl 1:E1660-5
pubmed: 26891064
Am J Physiol Regul Integr Comp Physiol. 2002 Jul;283(1):R86-98
pubmed: 12069934
Thorax. 2006 Aug;61(8):699-705
pubmed: 16601089
J Geriatr Oncol. 2013 Oct;4(4):327-33
pubmed: 24472475
Dysphagia. 2011 Jun;26(2):125-34
pubmed: 20454806
Transl Stroke Res. 2019 Feb;10(1):36-43
pubmed: 29603057
Clin Rehabil. 2002 Sep;16(6):640-5
pubmed: 12392339
Eur Arch Otorhinolaryngol. 2011 Dec;268(12):1837-44
pubmed: 21607581
Dysphagia. 2016 Dec;31(6):757-764
pubmed: 27461481
Dysphagia. 2007 Jul;22(3):225-34
pubmed: 17457548
Front Physiol. 2013 Jul 05;4:167
pubmed: 23847546
Pulm Pharmacol Ther. 2015 Apr;31:9-14
pubmed: 25634521
Dysphagia. 2000 Spring;15(2):58-67
pubmed: 10758187
Biomed Eng Online. 2015 Jan 12;14:3
pubmed: 25578623
Dysphagia. 2014 Apr;29(2):223-33
pubmed: 24402239
PLoS One. 2019 May 22;14(5):e0217366
pubmed: 31116792
Prev Vet Med. 2010 Sep 1;96(3-4):276-80
pubmed: 20633937
Radiother Oncol. 2006 Nov;81(2):143-50
pubmed: 17055096
Lung. 2007 Sep-Oct;185(5):243-248
pubmed: 17661135
Cough. 2011 Dec 01;7(1):11
pubmed: 22132691
Cough. 2006 Jan 25;2:1
pubmed: 16436200
Curr Phys Med Rehabil Rep. 2016 Dec;4(4):262-276
pubmed: 28529824
J Neuroeng Rehabil. 2016 Jan 22;13:7
pubmed: 26801236
Lung. 2011 Feb;189(1):73-9
pubmed: 21240613
Radiother Oncol. 2001 Dec;61(3):223-31
pubmed: 11730991
Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1849-55
pubmed: 26071622
J Clin Oncol. 2006 Jun 10;24(17):2636-43
pubmed: 16763277
Dysphagia. 2007 Oct;22(4):290-8
pubmed: 17554472
Support Care Cancer. 2014 Sep;22(9):2361-9
pubmed: 24687537
Chest. 2014 Dec;146(6):1633-1648
pubmed: 25188530
Dysphagia. 2018 Apr;33(2):206-215
pubmed: 28887707
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:2601-2605
pubmed: 31946429
IEEE J Transl Eng Health Med. 2015 Nov 25;3:2900310
pubmed: 27170905
Chest. 2009 Mar;135(3):769-777
pubmed: 19017886
Lung. 2008;186 Suppl 1:S48-54
pubmed: 18066694
J Physiol. 2012 Feb 1;590(3):563-74
pubmed: 22144580
Parkinsonism Relat Disord. 2014 Nov;20(11):1226-30
pubmed: 25246315
Pulm Pharmacol Ther. 2009 Apr;22(2):59-64
pubmed: 19049891
J Physiol Pharmacol. 2006 Sep;57 Suppl 4:149-56
pubmed: 17072041
Comput Methods Programs Biomed. 2017 Jun;144:179-187
pubmed: 28495001
J Allergy Clin Immunol. 2008 Nov;122(5):903-7
pubmed: 18842290
Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1170-9
pubmed: 12829156
Pulm Pharmacol Ther. 2007;20(4):307-12
pubmed: 17291801
Int Arch Otorhinolaryngol. 2015 Jan;19(1):46-54
pubmed: 25992151
J Hosp Med. 2015 Apr;10(4):256-65
pubmed: 25581840
Lung. 2008;186 Suppl 1:S107-11
pubmed: 17952695
Dysphagia. 1996 Spring;11(2):93-8
pubmed: 8721066
Proc SPIE Int Soc Opt Eng. 2014 May 23;9190:91090M
pubmed: 25332758
J Speech Lang Hear Res. 2010 Jun;53(3):620-32
pubmed: 20029051
J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 1):67-74
pubmed: 18204117
Indian J Surg Oncol. 2019 Jun;10(2):402-405
pubmed: 31168273
Multidiscip Respir Med. 2012 Jun 18;7(1):5
pubmed: 22958367
Dysphagia. 2015 Jun;30(3):343-8
pubmed: 25783698
Eur Respir J. 2006 Jul;28(1):10-5
pubmed: 16816346
Clin Exp Dent Res. 2017 Nov 16;3(6):209-214
pubmed: 29744203
Sensors (Basel). 2018 Nov 07;18(11):
pubmed: 30405015
Sensors (Basel). 2018 Jul 22;18(7):
pubmed: 30037130
Radiol Oncol. 2019 Jun 1;53(2):225-230
pubmed: 31194691
Eur Arch Otorhinolaryngol. 2015 Nov;272(11):3521-31
pubmed: 25381096
Physiol Behav. 2013 Jun 13;118:25-31
pubmed: 23672854
Thorax. 2007 Apr;62(4):329-34
pubmed: 17101736
Radiother Oncol. 2015 Apr;115(1):56-62
pubmed: 25792467
Head Neck. 2014 Jan;36(1):120-5
pubmed: 23729173
Eur Respir J. 2007 Jun;29(6):1256-76
pubmed: 17540788
Int J Chron Obstruct Pulmon Dis. 2018 Apr 03;13:1071-1078
pubmed: 29662309
Dysphagia. 2016 Aug;31(4):521-30
pubmed: 27115759
Dysphagia. 2016 Dec;31(6):738-748
pubmed: 27402004
Trials. 2013 Nov 07;14:377
pubmed: 24199872
Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1425-39
pubmed: 15590174
Oral Oncol. 2014 Aug;50(8):746-52
pubmed: 24906528
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:217-220
pubmed: 31945881
Med Biol Eng Comput. 2017 Jun;55(6):1001-1017
pubmed: 27665103
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):37-42
pubmed: 30652513
Yonsei Med J. 2019 Dec;60(12):1181-1186
pubmed: 31769249
Cancer. 2012 Dec 1;118(23):5793-9
pubmed: 23640737
Cough. 2013 Mar 06;9(1):7
pubmed: 23497672
Dysphagia. 2000 Spring;15(2):84-8
pubmed: 10758190
J Clin Oncol. 2008 Aug 1;26(22):3770-6
pubmed: 18669465
Oncologist. 2016 Sep;21(9):1091-8
pubmed: 27368883
Dysphagia. 2004 Fall;19(4):231-40
pubmed: 15667057
Cancer. 2015 Apr 15;121(8):1303-11
pubmed: 25537836
Dysphagia. 2011 Jun;26(2):150-4
pubmed: 20640582
Chest. 2010 Dec;138(6):1426-31
pubmed: 20705802
Head Neck. 2011 Sep;33(9):1335-9
pubmed: 21837705
Dysphagia. 2002 Summer;17(3):214-8
pubmed: 12140648
J Neurosci Nurs. 2009 Aug;41(4):178-85; quiz 186-7
pubmed: 19678503
Lung. 2012 Feb;190(1):29-33
pubmed: 22033612
IEEE Trans Hum Mach Syst. 2015 Aug;45(4):465-477
pubmed: 26213659
Lung. 2008;186 Suppl 1:S35-40
pubmed: 18196338

Auteurs

Sofiana Mootassim-Billah (S)

Department of Radiation Oncology, Speech Therapy, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Gwen Van Nuffelen (G)

Department of Otolaryngology and Head and Neck Surgery, University Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Department of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Department of Logopaedics and Audiological Sciences, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.

Jean Schoentgen (J)

BEAMS (Bio-, Electro- And Mechanical Systems), Université Libre de Bruxelles, Brussels, Belgium.

Marc De Bodt (M)

Department of Otolaryngology and Head and Neck Surgery, University Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Department of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Department of Logopaedics and Audiological Sciences, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.

Tatiana Dragan (T)

Department of Radiation Oncology, Head and Neck Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Antoine Digonnet (A)

Department of Surgical Oncology, Head and Neck Surgery Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Nicolas Roper (N)

Department of Oto-Rhino-Laryngology and Head & Neck Surgery, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Dirk Van Gestel (D)

Department of Radiation Oncology, Head and Neck Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH